missing translation for 'onlineSavingsMsg'
Learn More
Learn More
R&D Systems™ Recombinant Human Erythropoietin R Fc Chimera Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity
Brand: R&D Systems™ 963-ER-050
313.60 EUR valid until 2024-12-16
Use promo code "21630" to get your promotional price.
This item is not returnable.
View return policy
Description
The Recombinant Human Erythropoietin R Fc Chimera Protein is derived from NS0. The Recombinant Human Erythropoietin R Fc Chimera Protein has been validated for the following applications: Bioactivity.Specifications
| Lyophilized from a 0.2μm filtered solution in PBS, EDTA and CHAPS. | |
| 51.4 kDa (monomer) | |
| 50 μg | |
| Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution. | |
| Unconjugated | |
| 90%, by SDS-PAGE under reducing conditions and visualized by silver stain. |
| 2057 | |
| Erythropoietin R Fc Chimera | |
| Mouse myeloma cell line,NS0-derived human Erythropoietin R protein, (N-terminus) Human Epo R (Ala25-Pro250) Accession &Num; P19235 IEGRMD Human IgG1 (Pro100-Lys330) (C-terminus) | |
| Disulfide-linked homodimer | |
| Recombinant |